These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34715162)

  • 1. Predictive roles of brain-derived neurotrophic factor Val66Met polymorphism on antidepressant efficacy of different forms of prefrontal brain stimulation monotherapy: A randomized, double-blind, sham-controlled study.
    Cheng CM; Hong CJ; Lin HC; Chu PJ; Chen MH; Tu PC; Bai YM; Chang WH; Juan CH; Lin WC; Tsai SJ; Su TP; Li CT
    J Affect Disord; 2022 Jan; 297():353-359. PubMed ID: 34715162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant effects of prolonged intermittent theta-burst stimulation monotherapy at the bilateral dorsomedial prefrontal cortex for medication and standard transcranial magnetic stimulation-resistant major depression: a three arm, randomized, double blind, sham-controlled pilot study.
    Cheng CM; Li CT; Jeng JS; Chang WH; Lin WC; Chen MH; Bai YM; Tsai SJ; Su TP
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1433-1442. PubMed ID: 36484844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant Efficacy of Prolonged Intermittent Theta Burst Stimulation Monotherapy for Recurrent Depression and Comparison of Methods for Coil Positioning: A Randomized, Double-Blind, Sham-Controlled Study.
    Li CT; Cheng CM; Chen MH; Juan CH; Tu PC; Bai YM; Jeng JS; Lin WC; Tsai SJ; Su TP
    Biol Psychiatry; 2020 Mar; 87(5):443-450. PubMed ID: 31563272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Task-Modulated Brain Activity Predicts Antidepressant Responses of Prefrontal Repetitive Transcranial Magnetic Stimulation: A Randomized Sham-Control Study.
    Li CT; Cheng CM; Juan CH; Tsai YC; Chen MH; Bai YM; Tsai SJ; Su TP
    Chronic Stress (Thousand Oaks); 2021; 5():24705470211006855. PubMed ID: 33889790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The longer, the better ? Longer left-sided prolonged intermittent theta burst stimulation in patients with major depressive disorder: A randomized sham-controlled study.
    Li CT; Cheng CM; Lin HC; Yeh SH; Jeng JS; Wu HT; Bai YM; Tsai SJ; Su TP; Fitzgerald PB
    Asian J Psychiatr; 2023 Sep; 87():103686. PubMed ID: 37406605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of rhythms in prefrontal transcranial magnetic stimulation for depression: A randomized sham-controlled study.
    Tsai YC; Li CT; Liang WK; Muggleton NG; Tsai CC; Huang NE; Juan CH
    Hum Brain Mapp; 2022 Apr; 43(5):1535-1547. PubMed ID: 34873781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial.
    Krstić J; Buzadžić I; Milanović SD; Ilić NV; Pajić S; Ilić TV
    J ECT; 2014 Dec; 30(4):325-31. PubMed ID: 24625704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Updates on Newer Forms of Transcranial Magnetic Stimulation in Major Depression.
    Cheng CM; Li CT; Tsai SJ
    Adv Exp Med Biol; 2021; 1305():333-349. PubMed ID: 33834408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
    Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
    J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
    Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
    Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International randomized-controlled trial of transcranial Direct Current Stimulation in depression.
    Loo CK; Husain MM; McDonald WM; Aaronson S; O'Reardon JP; Alonzo A; Weickert CS; Martin DM; McClintock SM; Mohan A; Lisanby SH;
    Brain Stimul; 2018; 11(1):125-133. PubMed ID: 29111077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral theta-burst stimulation on emotional processing in major depressive disorder: A functional neuroimaging study from a randomized, double-blind, sham-controlled trial.
    Chou PH; Tu CH; Chen CM; Lu MK; Tsai CH; Hsieh WT; Lai HC; Satyanarayanan SK; Su KP
    Psychiatry Clin Neurosci; 2023 Apr; 77(4):233-240. PubMed ID: 36579902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of low-dose ketamine infusion and repetitive transcranial magnetic stimulation in treatment-resistant depression: A posthoc pooled analysis of two randomized, double-blind, placebo-controlled studies.
    Chen MH; Cheng CM; Li CT; Tsai SJ; Lin WC; Bai YM; Su TP
    Psychiatry Res; 2022 Oct; 316():114749. PubMed ID: 35940087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
    Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism.
    Martin S; Colle R; El Asmar K; Rigal A; Vievard A; Feve B; Becquemont L; Verstuyft C; Corruble E
    Psychol Med; 2019 Oct; 49(14):2364-2369. PubMed ID: 30526722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study.
    Li CT; Chen MH; Juan CH; Huang HH; Chen LF; Hsieh JC; Tu PC; Bai YM; Tsai SJ; Lee YC; Su TP
    Brain; 2014 Jul; 137(Pt 7):2088-98. PubMed ID: 24817188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
    Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
    Blumberger DM; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Downar J
    Lancet; 2018 Apr; 391(10131):1683-1692. PubMed ID: 29726344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.